Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.19 Billion EUR | 14.52% |
| 2022 | 5 Billion USD | 2.53% |
| 2021 | 4.88 Billion USD | 1.81% |
| 2020 | 4.79 Billion USD | 14.31% |
| 2019 | 4.19 Billion USD | 7.39% |
| 2018 | 3.9 Billion USD | 3.74% |
| 2017 | 3.76 Billion USD | 25.75% |
| 2016 | 2.99 Billion USD | 15.35% |
| 2015 | 2.59 Billion USD | 10.18% |
| 2014 | 2.35 Billion USD | 6.42% |
| 2013 | 2.21 Billion USD | 17.58% |
| 2012 | 1.88 Billion USD | 17.62% |
| 2011 | 1.6 Billion USD | 23.85% |
| 2010 | 1.29 Billion USD | 6.91% |
| 2009 | 1.2 Billion USD | 23.94% |
| 2008 | 976.26 Million USD | 22.61% |
| 2007 | 796.23 Million USD | 45.52% |
| 2006 | 547.16 Million USD | 49.81% |
| 2005 | 365.23 Million USD | 13.33% |
| 2004 | 322.26 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.96 Billion USD | 1.19% |
| 2023 Q4 | 2.93 Billion USD | 5.94% |
| 2023 Q1 | 1.26 Billion EUR | -46.8% |
| 2023 Q3 | 1.32 Billion EUR | -47.65% |
| 2023 FY | 5.19 Billion EUR | 11.04% |
| 2023 Q2 | 2.76 Billion USD | 8.45% |
| 2022 FY | 4.68 Billion EUR | 8.89% |
| 2022 Q4 | 2.55 Billion USD | 6.21% |
| 2022 Q3 | 1.19 Billion EUR | -48.0% |
| 2022 Q1 | 1.14 Billion EUR | -48.53% |
| 2022 Q2 | 2.4 Billion USD | -5.09% |
| 2021 Q4 | 2.53 Billion USD | 3.23% |
| 2021 FY | 4.29 Billion EUR | 9.59% |
| 2021 Q2 | 2.45 Billion USD | -0.61% |
| 2021 Q3 | 1.11 Billion EUR | -46.15% |
| 2021 Q1 | 1.03 Billion EUR | -48.73% |
| 2020 Q2 | 2.13 Billion USD | 0.3% |
| 2020 FY | 3.92 Billion EUR | 4.87% |
| 2020 Q1 | 952.07 Million EUR | -49.88% |
| 2020 Q4 | 2.46 Billion USD | 15.47% |
| 2020 Q3 | 1 Billion EUR | -47.0% |
| 2019 Q3 | 949.81 Million EUR | -48.4% |
| 2019 Q1 | 920.29 Million EUR | 5.73% |
| 2019 FY | 3.74 Billion EUR | 9.37% |
| 2019 Q2 | 2.09 Billion USD | 5.33% |
| 2019 Q4 | 2.13 Billion USD | 1.73% |
| 2018 Q4 | 1.98 Billion USD | 1.51% |
| 2018 Q3 | 870.38 Million EUR | 3.68% |
| 2018 Q2 | 1.96 Billion USD | 1.24% |
| 2018 Q1 | 839.49 Million EUR | 4.12% |
| 2018 FY | 3.41 Billion EUR | 8.97% |
| 2017 Q1 | 762.85 Million EUR | 4.45% |
| 2017 FY | 3.13 Billion EUR | 10.45% |
| 2017 Q3 | 806.25 Million EUR | 5.69% |
| 2017 Q4 | 1.93 Billion USD | 11.27% |
| 2017 Q2 | 1.74 Billion USD | 12.95% |
| 2016 Q4 | 1.54 Billion USD | 11.6% |
| 2016 FY | 2.84 Billion EUR | 18.8% |
| 2016 Q2 | 1.38 Billion EUR | 0.0% |
| 2016 Q3 | 730.36 Million EUR | 5.81% |
| 2016 Q1 | 690.25 Million EUR | 8.77% |
| 2015 Q3 | 634.59 Million EUR | 13.08% |
| 2015 Q4 | 634.59 Million EUR | 0.0% |
| 2015 FY | 2.39 Billion EUR | 22.74% |
| 2015 Q1 | 561.2 Million EUR | 6.1% |
| 2015 Q2 | 561.2 Million EUR | 0.0% |
| 2014 Q1 | 445.34 Million EUR | 7.91% |
| 2014 FY | 1.94 Billion EUR | 21.19% |
| 2014 Q4 | 528.94 Million EUR | 0.0% |
| 2014 Q3 | 528.94 Million EUR | 18.77% |
| 2014 Q2 | 445.34 Million EUR | 0.0% |
| 2013 Q2 | 391.24 Million EUR | 0.0% |
| 2013 Q4 | 412.72 Million EUR | 0.0% |
| 2013 FY | 1.6 Billion EUR | 12.5% |
| 2013 Q1 | 391.24 Million EUR | 0.0% |
| 2013 Q3 | 412.72 Million EUR | 5.49% |
| 2012 FY | 1.42 Billion EUR | 15.81% |
| 2011 FY | 1.23 Billion EUR | 27.99% |
| 2010 FY | 964.23 Million EUR | 14.34% |
| 2009 FY | 843.32 Million EUR | 20.08% |
| 2008 FY | 702.32 Million EUR | 28.96% |
| 2007 FY | 544.6 Million EUR | 31.25% |
| 2006 FY | 414.94 Million EUR | 34.01% |
| 2005 FY | 309.63 Million EUR | 30.6% |
| 2004 FY | 237.08 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| The Amacore Group, Inc. | 28.82 Million USD | -17929.923% |
| Arem Pacific Corporation | 343.47 Thousand USD | -1513238.516% |
| Assisted 4 Living, Inc. | 880.78 Thousand USD | -590057.383% |
| BioCorRx Inc. | 89.16 Thousand USD | -5829868.596% |
| Bionik Laboratories Corp. | 1.8 Million USD | -287845.615% |
| Banyan Corp. | 5 Million USD | -103783.334% |
| Clearday, Inc. | 12.48 Million USD | -41522.123% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -160035.403% |
| Quantum Medical Transport, Inc. | 1310.14 USD | -396751392.207% |
| Empower Clinics Inc. | 4.66 Million USD | -111408.573% |
| First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -17335234.334% |
| Selectis Health, Inc. | 36.78 Million USD | -14031.51% |
| Ethema Health Corporation | 5.34 Million USD | -97150.203% |
| HealthLynked Corp. | 5.72 Million USD | -90736.346% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.24 Million USD | -56101.983% |
| JRSIS Health Care Corporation | 3.46 Million USD | -150047.331% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 453.75 Million USD | -1045.556% |
| MedSmart Group Inc. | - USD | -Infinity% |
| North America Frac Sand, Inc. | 137.3 Thousand USD | -3785632.493% |
| Nova Leap Health Corp. | 26.17 Million USD | -19755.59% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -1478019.677% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -49396.824% |
| Raffles Medical Group Ltd | 536.52 Million USD | -868.825% |
| Ryman Healthcare Limited | 650.53 Million USD | -699.036% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 4.61 Million USD | -112567.753% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
| Veltex Corporation | 838.65 Thousand USD | -619702.684% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 1.12 Million USD | -463144.763% |